AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,042,569 | -15.8% | 42,124 | -3.7% | 0.00% | 0.0% |
| Q2 2023 | $1,238,688 | +18.3% | 43,739 | -4.1% | 0.00% | 0.0% |
| Q1 2023 | $1,047,501 | -22.4% | 45,603 | -5.1% | 0.00% | -25.0% |
| Q4 2022 | $1,349,300 | -4.0% | 48,052 | -3.3% | 0.00% | 0.0% |
| Q3 2022 | $1,405,000 | +19.0% | 49,697 | -6.7% | 0.00% | +33.3% |
| Q2 2022 | $1,181,000 | -49.2% | 53,259 | -33.3% | 0.00% | -40.0% |
| Q1 2022 | $2,326,000 | -11.4% | 79,900 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $2,626,000 | -28.8% | 79,900 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $3,687,000 | -16.3% | 79,900 | 0.0% | 0.01% | -11.1% |
| Q2 2021 | $4,403,000 | +995.3% | 79,900 | +925.7% | 0.01% | +800.0% |
| Q1 2021 | $402,000 | +17.2% | 7,790 | -1.5% | 0.00% | 0.0% |
| Q4 2020 | $343,000 | +19.1% | 7,905 | -4.0% | 0.00% | 0.0% |
| Q3 2020 | $288,000 | -33.3% | 8,235 | +2.0% | 0.00% | 0.0% |
| Q2 2020 | $432,000 | +49.5% | 8,075 | -0.9% | 0.00% | 0.0% |
| Q1 2020 | $289,000 | -29.2% | 8,145 | -4.7% | 0.00% | 0.0% |
| Q4 2019 | $408,000 | +72.2% | 8,545 | +17.0% | 0.00% | 0.0% |
| Q3 2019 | $237,000 | -35.4% | 7,305 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $367,000 | -42.3% | 7,360 | -21.9% | 0.00% | -50.0% |
| Q1 2019 | $636,000 | +42.0% | 9,426 | -2.9% | 0.00% | +100.0% |
| Q4 2018 | $448,000 | -40.2% | 9,706 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $749,000 | -10.4% | 9,706 | -2.3% | 0.00% | 0.0% |
| Q2 2018 | $836,000 | +3.2% | 9,931 | +0.3% | 0.00% | 0.0% |
| Q1 2018 | $810,000 | +65.6% | 9,904 | +15.7% | 0.00% | +100.0% |
| Q4 2017 | $489,000 | -13.3% | 8,559 | +1.3% | 0.00% | -50.0% |
| Q3 2017 | $564,000 | +32.4% | 8,449 | +2.1% | 0.00% | +100.0% |
| Q2 2017 | $426,000 | +17.7% | 8,274 | +33.6% | 0.00% | 0.0% |
| Q1 2017 | $362,000 | -49.2% | 6,194 | -63.8% | 0.00% | -66.7% |
| Q4 2016 | $713,000 | -31.7% | 17,096 | -13.5% | 0.00% | -25.0% |
| Q3 2016 | $1,044,000 | +34.9% | 19,770 | +7.0% | 0.00% | +33.3% |
| Q2 2016 | $774,000 | +6.6% | 18,470 | +3.4% | 0.00% | 0.0% |
| Q1 2016 | $726,000 | -40.6% | 17,870 | -5.1% | 0.00% | -40.0% |
| Q4 2015 | $1,223,000 | -10.2% | 18,840 | -2.3% | 0.01% | 0.0% |
| Q3 2015 | $1,362,000 | -38.1% | 19,290 | -2.6% | 0.01% | -37.5% |
| Q2 2015 | $2,201,000 | – | 19,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |